Toxicity of maintenance drugs in Inflammatory Bowel Disease
Received Date: August 04, 2021; Published Date: September 07, 2021
Inflammatory bowel disease is a chronic condition requiring long-term treatment with immunosuppressive medications. There is concern regarding the risks of drug-related toxicity particularly the risk of infections and the risk of malignancy. Pregnancy requires a particular consideration due to the implications from the exposure to the fetus and elderly patients may be at a higher risk of toxicity that merits special precautions.
Keywords: 5-Aminosalicylates; Immunomodulators; Biologics; Toxicity; Inflammatory Bowel Disease; Crohn’s Disease; Ulcerative Colitis